307 related articles for article (PubMed ID: 36630897)
21. A patient with AL amyloidosis with negative free light chain results.
Milani P; Valentini V; Ferraro G; Basset M; Russo F; Foli A; Palladini G; Merlini G
Clin Chem Lab Med; 2016 Jun; 54(6):1035-7. PubMed ID: 26677890
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2022 Jun; 97(6):818-829. PubMed ID: 35429180
[TBL] [Abstract][Full Text] [Related]
23. Biomarkers in AL Amyloidosis.
Fotiou D; Theodorakakou F; Kastritis E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681575
[TBL] [Abstract][Full Text] [Related]
24. [Interest of daratumumab in refractory AL amyloidosis in a 96-year-old patient].
Vial G; Lafargue A; Mercié P; Duffau P; Ribeiro E
Rev Med Interne; 2022 Nov; 43(11):673-676. PubMed ID: 35934598
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in understanding and treating immunoglobulin light chain amyloidosis.
Badar T; D'Souza A; Hari P
F1000Res; 2018; 7():. PubMed ID: 30228867
[TBL] [Abstract][Full Text] [Related]
26. [AL Amyloidosis].
Ueda M
Brain Nerve; 2024 May; 76(5):583-587. PubMed ID: 38741500
[TBL] [Abstract][Full Text] [Related]
27. Bad players in AL amyloidosis in the current era of treatment.
Kreiniz N; Gertz MA
Expert Rev Hematol; 2023 Jan; 16(1):33-49. PubMed ID: 36620914
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and management of systemic light chain AL amyloidosis.
Bhutani D; Lentzsch S
Pharmacol Ther; 2020 Oct; 214():107612. PubMed ID: 32562825
[TBL] [Abstract][Full Text] [Related]
29. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.
Nasr SH; Said SM; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Dispenzieri A; Buadi FK; Vrana JA; Theis JD; Dogan A; Leung N
Kidney Int; 2013 Mar; 83(3):463-70. PubMed ID: 23302715
[TBL] [Abstract][Full Text] [Related]
30. Immunoglobulin Light-Chain Amyloidosis: From Basics to New Developments in Diagnosis, Prognosis and Therapy.
Muchtar E; Buadi FK; Dispenzieri A; Gertz MA
Acta Haematol; 2016; 135(3):172-90. PubMed ID: 26771835
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis.
Puig N; Paiva B; Lasa M; Burgos L; Perez JJ; Merino J; Moreno C; Vidriales MB; Toboso DG; Cedena MT; Ocio EM; Lecumberri R; García de Coca A; Labrador J; Gonzalez ME; Palomera L; Gironella M; Cabañas V; Casanova M; Oriol A; Krsnik I; Pérez-Montaña A; de la Rubia J; de la Puerta JE; de Arriba F; Prosper F; Martinez-Lopez J; Lecrevisse Q; Verde J; Mateos MV; Lahuerta JJ; Orfao A; San Miguel JF
Leukemia; 2019 May; 33(5):1256-1267. PubMed ID: 30542145
[TBL] [Abstract][Full Text] [Related]
32. Nonchemotherapy Treatment of Immunoglobulin Light Chain Amyloidosis.
Van Doren L; Lentzsch S
Acta Haematol; 2020; 143(4):373-380. PubMed ID: 32526750
[TBL] [Abstract][Full Text] [Related]
33. Clinical and morphological diagnosis of cardiac AL amyloidosis: a review of findings and difficulties as illustrated in one case.
Prochorec-Sobieszek M; Szufladowicz E; Szaroszyk W; Wagner T; Loukas M
Med Sci Monit; 2005 Aug; 11(8):CS45-8. PubMed ID: 16049384
[TBL] [Abstract][Full Text] [Related]
34. Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis.
Granzow M; Hegenbart U; Hinderhofer K; Hose D; Seckinger A; Bochtler T; Hemminki K; Goldschmidt H; Schönland SO; Jauch A
Haematologica; 2017 Jul; 102(7):1281-1290. PubMed ID: 28341732
[TBL] [Abstract][Full Text] [Related]
35. AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
Manabe S; Iwasaki C; Hatano M; Kametani F; Yazaki M; Nitta K; Nagata M
BMC Nephrol; 2018 Nov; 19(1):337. PubMed ID: 30466387
[TBL] [Abstract][Full Text] [Related]
36. AL amyloidosis with a localized B cell neoplasia.
Stuhlmann-Laeisz C; Schönland SO; Hegenbart U; Oschlies I; Baumgart JV; Krüger S; Röcken C
Virchows Arch; 2019 Mar; 474(3):353-363. PubMed ID: 30680453
[TBL] [Abstract][Full Text] [Related]
37. Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation.
Sidiqi MH; Aljama MA; Jevremovic D; Morice WG; Timm M; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Gonsalves WI; Kumar S; Kapoor P; Kourelis T; Leung N; Hogan WJ; Gertz M
Haematologica; 2018 Jul; 103(7):1229-1234. PubMed ID: 29674497
[TBL] [Abstract][Full Text] [Related]
38. Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update.
Muchtar E; Dispenzieri A; Gertz MA; Kumar SK; Buadi FK; Leung N; Lacy MQ; Dingli D; Ailawadhi S; Bergsagel PL; Fonseca R; Hayman SR; Kapoor P; Grogan M; Abou Ezzeddine OF; Rosenthal JL; Mauermann M; Siddiqui M; Gonsalves WI; Kourelis TV; Larsen JT; Reeder CB; Warsame R; Go RS; Murray DL; McPhail ED; Dasari S; Jevremovic D; Kyle RA; Lin Y; Lust JA; Russell SJ; Hwa YL; Fonder AL; Hobbs MA; Rajkumar SV; Roy V; Sher T
Mayo Clin Proc; 2021 Jun; 96(6):1546-1577. PubMed ID: 34088417
[TBL] [Abstract][Full Text] [Related]
39. Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis.
Kim D; Choi JO; Kim K; Kim SJ; Kim JS; Jeon ES
ESC Heart Fail; 2021 Dec; 8(6):5594-5599. PubMed ID: 34528755
[TBL] [Abstract][Full Text] [Related]
40. Combined Subcutaneous Fat Aspirate and Skin Tru-Cut Biopsy for Amyloid Screening in Patients with Suspected Systemic Amyloidosis.
Hansen CT; Møller HEH; Rojek AM; Marcussen N; Beck HC; Abildgaard N
Molecules; 2021 Jun; 26(12):. PubMed ID: 34203841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]